PANKLAV FORTE

Powder for oral suspension, 250mg/5ml + 62.5mg/5ml
RxActive license

Active substance (INN)

amoxicillinclavulanic acid

Pharmaceutical form

Pharmaceutical formPowder for oral suspension
Strength250mg/5ml + 62.5mg/5ml
PackagingUkupno 1 bočica staklena sa praškom za oralnu suspenziju u kartonskoj kutiji
ManufacturerHemofarm a.d. Vršac, Serbia
Therapeutic groupAnti-infectives for systemic use (J01CR02)
Marketing authorization holderDRUŠTVO SA OGRANIČENOM ODGOVORNOŠĆU "HEMOMONT" ZA PROIZVODNJU FARMACEUTSKIH PROIZVODA PODGORICA
Authorization dateDecember 24, 2025

Analogs in Montenegro

20

Other medicines with the same active substance

Source: CInMED register